Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000926617-23-000026
Filing Date
2023-03-30
Accepted
2023-03-30 08:01:49
Documents
74
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 10-K awh-20221231x10k.htm   iXBRL 10-K 3487471
2 EX-10.32 awh-20221231xex10_32.htm EX-10.32 101869
3 EX-10.33 awh-20221231xex10_33.htm EX-10.33 95755
4 EX-23.1 awh-20221231xex23_1.htm EX-23.1 5775
5 EX-31.1 awh-20221231xex31_1.htm EX-31.1 22910
6 EX-31.2 awh-20221231xex31_2.htm EX-31.2 22936
7 EX-32.1 awh-20221231xex32_1.htm EX-32.1 14128
  Complete submission text file 0000926617-23-000026.txt   12194140

Data Files

Seq Description Document Type Size
8 EX-101.SCH awh-20221231.xsd EX-101.SCH 49232
9 EX-101.CAL awh-20221231_cal.xml EX-101.CAL 58166
10 EX-101.DEF awh-20221231_def.xml EX-101.DEF 186955
11 EX-101.LAB awh-20221231_lab.xml EX-101.LAB 445527
12 EX-101.PRE awh-20221231_pre.xml EX-101.PRE 394576
68 EXTRACTED XBRL INSTANCE DOCUMENT awh-20221231x10k_htm.xml XML 2530739
Mailing Address 12117 BEE CAVES ROAD BUILDING THREE SUITE 100 AUSTIN TX 78738
Business Address 12117 BEE CAVES ROAD BUILDING THREE SUITE 100 AUSTIN TX 78738 512-519-0400
Aspira Women's Health Inc. (Filer) CIK: 0000926617 (see all company filings)

EIN.: 330595156 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-34810 | Film No.: 23777197
SIC: 2835 In Vitro & In Vivo Diagnostic Substances